Renal transplantation in HIV-infected patients: 2010 update.

[1]  J. Miro,et al.  Are HIV-infected donors suitable for renal transplantation? , 2011, Transplantation.

[2]  A. Mocroft,et al.  Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey , 2010, Journal of acquired immune deficiency syndromes.

[3]  D. Stablein,et al.  Outcomes of kidney transplantation in HIV-infected recipients. , 2010, The New England journal of medicine.

[4]  J. Miro,et al.  Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review. , 2010, Transplantation Proceedings.

[5]  M. Delahousse,et al.  Renal Transplantation in HIV‐Infected Patients: The Paris Experience , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  P. Cavadas,et al.  Kidney transplants in HIV-positive recipients under HAART. A comprehensive review and meta-analysis of 12 series. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  R. Bosch,et al.  Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328) , 2010, AIDS research and therapy.

[8]  M. Mendelson,et al.  Renal transplantation between HIV-positive donors and recipients. , 2010, The New England journal of medicine.

[9]  Plan Nacional sobre el Sida,et al.  [AIDS Study Group/Spanish AIDS Plan consensus document on antiretroviral therapy in adults with human immunodeficiency virus infection (updated January 2010)]. , 2010, Enfermedades infecciosas y microbiologia clinica.

[10]  F. Crescentini,et al.  Simultaneous pancreas-kidney transplantation in a human immunodeficiency virus-positive recipient: a case report. , 2010, Transplantation proceedings.

[11]  A. Horban,et al.  The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml , 2010, AIDS.

[12]  P. Stock,et al.  Solid Organ Transplantation in the HIV‐Infected Patient , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  N. Arzouk,et al.  Kidney transplantation in HIV-positive patients: report of our first 7 cases. , 2009, Transplantation proceedings.

[14]  M. Delahousse,et al.  Safety and Efficacy of Raltegravir in HIV‐Infected Transplant Patients Cotreated with Immunosuppressive Drugs , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  J. Bromberg,et al.  Factors Associated with Failure to List HIV‐Positive Kidney Transplant Candidates , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  J. Miro,et al.  Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study. , 2008, AIDS research and human retroviruses.

[17]  L. Szczech,et al.  The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis , 2008, AIDS.

[18]  M. Masetti,et al.  Combined liver-kidney transplantation in an HIV-HCV-coinfected patient with haemophilia. , 2008, AIDS.

[19]  S. Hammer,et al.  Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. , 2008, JAMA.

[20]  S. Gruber,et al.  Preliminary Experience With Renal Transplantation in HIV+ Recipients: Low Acute Rejection and Infection Rates , 2008, Transplantation.

[21]  M. Fishbein,et al.  Combined CXCR3/CCR5 Blockade Attenuates Acute and Chronic Rejection1 , 2008, The Journal of Immunology.

[22]  A. Dhai,et al.  Uniquely South African: time to consider offering HIV-positive donor kidneys to HIV-infected renal failure patients? , 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[23]  P. Tebas,et al.  Enfuvirtide Does Not Require Dose Adjustment in Patients With Chronic Kidney Failure: Results of a Pharmacokinetic Study of Enfuvirtide in HIV-1-Infected Patients With Impaired Kidney Function , 2008, Journal of acquired immune deficiency syndromes.

[24]  C. Quereda,et al.  Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation. , 2008, AIDS.

[25]  D. Stablein,et al.  HIV‐Infected Liver and Kidney Transplant Recipients: 1‐ and 3‐Year Outcomes , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  J. Arribas,et al.  Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV , 2008, AIDS.

[27]  D. Fine,et al.  Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Peter Bacchetti,et al.  Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  L. Benet,et al.  Immunosuppressant Pharmacokinetics and Dosing Modifications in HIV‐1 Infected Liver and Kidney Transplant Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  C. López-Larrea,et al.  Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report. , 2007, Transplantation proceedings.

[31]  J. Miro,et al.  Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients. , 2007, AIDS research and human retroviruses.

[32]  A. Heredia,et al.  Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment , 2007, AIDS.

[33]  G. Pantaleo,et al.  Effects of immunosuppressive drugs on HIV infection: implications for solid‐organ transplantation , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[34]  T. Macgregor,et al.  Steady-State Disposition of the Nonpeptidic Protease Inhibitor Tipranavir when Coadministered with Ritonavir , 2007, Antimicrobial Agents and Chemotherapy.

[35]  J. Miro,et al.  Liver transplantation in HIV/hepatitis co-infection. , 2007, Journal of HIV therapy.

[36]  J. Bragg-Gresham,et al.  Outcome and prognosis factors in HIV-infected hemodialysis patients. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[37]  D. Fine,et al.  Antiretroviral therapy in the treatment of HIV-associated nephropathy. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  D. Gjertson,et al.  HIV-Positive Renal Recipients Can Achieve Survival Rates Similar to Those of HIV-Negative Patients , 2006, Transplantation.

[39]  F. Goebel,et al.  HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  M. Masetti,et al.  Pharmacokinetic interaction between Amprenavir/Ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation. , 2006, Transplantation proceedings.

[41]  J. Carter,et al.  Thymoglobulin‐Associated Cd4+ T‐Cell Depletion and Infection Risk in HIV‐Infected Renal Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[42]  S. Bhagani,et al.  Guidelines for kidney transplantation in patients with HIV disease * , 2006, HIV medicine.

[43]  J. Fellay,et al.  HIV and solid organ transplantation: the Swiss experience. , 2006, Swiss medical weekly.

[44]  L. Rostaing,et al.  Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients. , 2005, Transplantation.

[45]  José A. Salvador,et al.  Documento de consenso GESIDA/GESITRA-SEIMC, SPNS y ONT sobre trasplante de órgano sólido en pacientes infectados por el VIH en España (marzo 2005) , 2005 .

[46]  K. Tashima,et al.  Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  J. A. Oliver,et al.  [Prevalence of HIV-1-infection in dialysis units in Spain and potential candidates for renal transplantation: results of a Spanish survey]. , 2005, Enfermedades infecciosas y microbiologia clinica.

[48]  Rosa Polo,et al.  Trasplante renal en pacientes infectados por el VIH , 2005 .

[49]  J. M. Miró,et al.  Prevalencia de la infección por el VIH en centros de diálisis en España y potenciales candidatos para trasplante renal: resultados de una encuesta española , 2005 .

[50]  B. Maes,et al.  Risk Factors for Cardiovascular Events After Successful Renal Transplantation , 2005, Transplantation.

[51]  P. Francioli,et al.  Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  A. Flahault,et al.  The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002. , 2005, Kidney international.

[53]  M. Moritz,et al.  Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. , 2005, Kidney international.

[54]  L. Gesualdo,et al.  Sirolimus for Kaposi's sarcoma in renal-transplant recipients. , 2005, The New England journal of medicine.

[55]  E. Daugas,et al.  HAART-related nephropathies in HIV-infected patients. , 2005, Kidney international.

[56]  M. Schnitzler,et al.  The Impact of Transplantation with Deceased Donor Hepatitis C‐Positive Kidneys on Survival in Wait‐Listed Long‐term Dialysis Patients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[57]  S. Pol,et al.  Histopathologic Efficacy of Ribavirin Monotherapy in Kidney Allograft Recipients with Chronic Hepatitis C , 2004, Transplantation.

[58]  P. Anderson,et al.  6th International Workshop on Clinical Pharmacology of HIV Therapy , 2004, Expert opinion on pharmacotherapy.

[59]  M. Vogel,et al.  Management of drug‐to‐drug interactions between cyclosporine A and the protease‐inhibitor lopinavir/ritonavir in liver‐transplanted HIV‐infected patients , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[60]  P. Kimmel,et al.  Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. , 2004, Journal of the American Society of Nephrology : JASN.

[61]  M. Shullo,et al.  Tacrolimus and Lopinavir/Ritonavir Interaction in Liver Transplantation , 2003, The Annals of pharmacotherapy.

[62]  H. Izzedine,et al.  Pharmacokinetics of tenofovir in haemodialysis. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[63]  B. Lo,et al.  Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients. , 2003, Archives of internal medicine.

[64]  James R. Johnson.  Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations, and Genetic Investigations , 2003 .

[65]  J. Palefsky,et al.  Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study1 , 2003, Transplantation.

[66]  M. Mendelson,et al.  Determinants of survival among HIV-infected chronic dialysis patients. , 2003, Journal of the American Society of Nephrology : JASN.

[67]  J. Chave,et al.  Kidney‐Pancreas Transplantation in a Long‐Term Non‐Progressor HIV‐Infected Recipient , 2003 .

[68]  E. Schiff,et al.  Orthotopic liver transplantation in patients with human immunodeficiency virus and end‐stage liver disease , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[69]  P. Stock,et al.  Review of solid-organ transplantation in HIV-infected patients , 2003, Transplantation.

[70]  J. Fung,et al.  The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[71]  L. Shaw,et al.  The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA. , 2002, Journal of acquired immune deficiency syndromes.

[72]  A. Kirk,et al.  Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[73]  A. Mocroft,et al.  Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study , 2002, AIDS.

[74]  J. Grady,et al.  Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. , 2002, Journal of the American Society of Nephrology : JASN.

[75]  D. Margolis,et al.  Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. , 2002, Antiviral research.

[76]  A. Humar,et al.  Probable interaction between efavirenz and cyclosporine. , 2002, AIDS.

[77]  J. Roberts,et al.  Solid organ transplantation in HIV-positive patients. , 2001, Transplantation proceedings.

[78]  Klemens Budde,et al.  CC chemokine receptor 5 and renal-transplant survival , 2001, The Lancet.

[79]  P. Stock,et al.  Transplantation in the HIV+ Patient , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[80]  B. Charpentier,et al.  Lack of removal of nelfinavir during a haemodialysis session in an HIV-1 infected patient with hepatic and renal insufficiency. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[81]  P. Cleary,et al.  Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? , 2000, The New England journal of medicine.

[82]  G. Pantaleo,et al.  Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo , 2000, Nature Medicine.

[83]  Gill Mj,et al.  Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis. , 2000 .

[84]  F. Aweeka,et al.  Antiviral therapy for HIV patients with renal insufficiency. , 1999, Journal of acquired immune deficiency syndromes.

[85]  D. Wolf,et al.  Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. , 1999, Transplantation.

[86]  D. Burger,et al.  Pharmacokinetic Interaction between Saquinavir and Cyclosporine , 1998, Annals of Internal Medicine.

[87]  S. Bertoli,et al.  HIV infection in dialysis centers in Italy: a nationwide multicenter study. , 1998, Journal of nephrology.

[88]  J. Barrio,et al.  Indinavir pharmacokinetics in haemodialysis-dependent end-stage renal failure. , 1998, AIDS.

[89]  D. Streblow,et al.  Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A. , 1998, Virology.

[90]  R. Arthur,et al.  HIV infection in renal dialysis patients in Egypt. , 1994, AIDS.

[91]  M. Mihatsch,et al.  THE EFFECT OF CYCLOSPORINE ON THE PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION TRANSMITTED BY TRANSPLANTATION–DATA ON FOUR CASES AND REVIEW OF THE LITERATURE , 1993, Transplantation.

[92]  S. Holmberg,et al.  Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. , 1992, The New England journal of medicine.

[93]  H. Balfour,et al.  Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. , 1991, Reviews of infectious diseases.

[94]  T E Starzl,et al.  Transplantation in HIV+ patients. , 1990, Transplantation.

[95]  V. Briner,et al.  [HIV infection caused by kidney transplant: case report and review of 18 published cases]. , 1989, Schweizerische medizinische Wochenschrift.

[96]  J. Ward,et al.  Acute human immunodeficiency virus infection. Antigen detection and seroconversion in immunosuppressed patients. , 1989, Transplantation.

[97]  G. Sirchia,et al.  HIV infection in cadaveric renal allograft recipients in the North Italy Transplant Program. , 1989, Transplantation.

[98]  H. Uehara,et al.  Prevalence of ATLV and HIV among hemodialysis patients in Japan. , 1988, Nephron.

[99]  J. Bourgoignie,et al.  Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. , 1988, Kidney international.

[100]  G. Appel,et al.  Determination of acquired immunodeficiency syndrome (AIDS) after renal transplantation. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[101]  A. Schwarz,et al.  Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients. , 1987, Transplantation.

[102]  W. Saxinger,et al.  Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. , 1987, Annals of internal medicine.

[103]  H. Perkins,et al.  Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients. , 1987, Transplantation proceedings.

[104]  S. Flechner,et al.  Investigation of human T-lymphotropic virus III serology in a renal transplant population. , 1987, Transplantation proceedings.

[105]  D. Fuchs,et al.  HIV INFECTION IN RENAL ALLOGRAFT RECIPIENTS , 1986, The Lancet.

[106]  A. Schwarz,et al.  HTLV-III INFECTION IN KIDNEY TRANSPLANT RECIPIENTS , 1985, The Lancet.

[107]  R. Manfro,et al.  TRANSMISSION OF AIDS VIRUS AT RENAL TRANSPLANTATION , 1985, The Lancet.

[108]  D. Davies,et al.  MYOCARDIAL DISORDERS IN THE ELDERLY. , 1963, Lancet.

[109]  G. B. Dowling,et al.  Vitamin D in cutaneous tuberculosis. , 1947, Lancet.

[110]  D. Fine,et al.  Renal Disease in Patients with HIV Infection , 2012, Drugs.

[111]  J. Pascual,et al.  [Renal transplantation in HIV-infected patients in Spain]. , 2006, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[112]  B. Kearney,et al.  Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment , 2006, Clinical pharmacokinetics.

[113]  E. Acosta,et al.  Tipranavir , 2006, Clinical pharmacokinetics.

[114]  L. Finelli,et al.  National surveillance of dialysis-associated diseases in the United States, 2002. , 2005, Seminars in dialysis.

[115]  M. Sobh,et al.  The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[116]  J. Beijnen,et al.  Effect of Mycophenolate Mofetil on the Pharmacokinetics of Antiretroviral Drugs and on Intracellular Nucleoside Triphosphate Pools , 2004, Clinical pharmacokinetics.

[117]  A. Sobel,et al.  [Prevalence of HIV infection in dialysis patients: results of a national multicenter study]. , 1999, Nephrologie.

[118]  B. Zingman,et al.  Long-term survival in an HIV-infected renal transplant recipient. , 1997, American journal of nephrology.

[119]  J. Ehrich,et al.  Combined report on regular dialysis and transplantation of children in Europe, 1990. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[120]  G. Kootstra,et al.  A survey of vascular access for haemodialysis in The Netherlands. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[121]  V. Andreucci,et al.  International Yearbook of Nephrology 1991 , 1990 .

[122]  P. A. Bowen,et al.  Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production. , 1988, Annals of internal medicine.

[123]  A. Baretta,et al.  Acquired Immunodeficiency Syndrome Transmitted by Transplanted Kidney: Clinical Course During Maintenance Haemodialyis , 1988 .